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1. Introduction 
Glutamine accelerates the degradation of glutamine 
synthetase (GS, L-glutamate:ammonia ligase (ADP) 
EC 6.3 .1.2) in cultured rat hepatoma (HTC) cells [ 11. 
The mechanism of this regulatory process, in which 
the product of an enzymatic reaction accelerates the 
degradation of the enzyme producing it, is not well 
understood. Apparently glutamine does not facilitate 
GS degradation simply by binding to itsactive site [2]. 
Inhibitors of protein synthesis prevent the decay of 
GS activity caused by glutamine [3]. It has therefore 
been proposed that a labile polypeptide factor is 
implicated in the process [3]. In this respect the GS 
system resembles certain other protein degradative 
systems which require concomitant protein synthesis 
for activity [4]. 
The aim of the present investigation was to examine 
the effects of inhibitors of messenger RNA synthesis 
and of enucleation on GS degradation. It is shown 
that inhibitors of RNA synthesis inhibit the glutamine 
dependent degradation of GS. The inhibition increases 
progressively with time of incubation and is complete 
after incubations of x h. Enucleation of cells with 
cytochalasin B immediately inhibits the degradation 
of GS. These results are discussed in terms of a model 
proposed earlier for the degradation of glutamine syn- 
thetase. 
2. Materials and methods 
2 .I . Materials 
Actinomycin D and cordycepin (3’deoxyadeno- 
sine) were from Sigma. Cytochalasin B was from Serva 
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and cY-amanitin was purchased from Boehringer. Calf 
serum was obtained from Bio-Lab, Israel. [4-3H]- 
Leucine was purchased from the Nuclear Research 
Center, Israel. 
2.2. Growth of cells and induction of GS 
Hepatoma tissue culture cells, subclone GM 22, 
were grown in suspension, as in [5]. Glutamine syn- 
thetase was induced with methionine sulfone, as out- 
lined in [I]. The composition of growth medium and 
induction medium were the same as in [ 11. 
2 -3. Enucleation of cells 
Cells in suspension were enucleated with the aid of 
cytochalasin B as in [6]. Staining with Giemsa stain 
showed that the cytoplasts were essentially free from 
nucleated cells (<2%). 
2.4. Labeling of long-lived proteins 
Cells were incubated in growth medium with 
1 &i/ml of [3H]leucine for 36 h. They were then 
washed once with growth medium, containing 1 mM 
leucine, and incubated in the same medium for a fur- 
ther 10 h before the start of the experiment. 
2.5. Labeling of short-lived proteins 
Cells were incubated in growth medium with 
5 &i/ml of [ 3H]leucine for 30 min, washed once with 
growth medium, containing 1 mM leucine, and used 
immediately for the experiment. 
2.6. Intracellular protein degradation 
Labeled cells or cytoplasts prepared from them 
were incubated at a density of 5 X lO’/ml, at 37”C, 
in growth medium containing I mM leucine, with 
gentle shaking. Samples of 1 .O ml were removed at 
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Fig.1. The effect of cordycepin and actinomycin D on the glutaminedependent inactivation of GS. HTC cells were induced as in 
section 2. The cells were suspended in fresh induction medium and incubated as in [ 11. To one set of 5 vessels 15 wg cordycepin/ 
ml was added. To another set 1 pg actinomycin D/ml was added, and a third set contained no additions. At different times 5 mM 
glutamine was added to each system (0). One system (-GLN) remained without glutamine (0). Incubation was continued for a 
further time. Samples were taken and GS activity and amount of protein were estimated. 
intervals and the cells were sedimented. To the super- 
natant trichloroacetic acid was added to 10% final 
cont. (w/v). After 10 min at 0°C the precipitate was 
removed by centrifugation, and trichloroacetic acid- 
soluble counts were measured on 0.5 ml supernatant 
in a 10 ml toluene-Triton X-100 (2:l) scintillation 
mixture. The counts in the cell pellet were determined 
after suspension in 1 ml 1 .O N NaOH. ‘% Trichloro- 
acetic acid-soluble cpm’ are the percentage of the total 
counts in the sample, which are present in the trichlo- 
roacetic acid supematant. 
2.7. Analytical methods 
GS activity was determined by the glutamotrans- 
ferase assay as in [S]. Protein was measured as in [ 71 
using bovine plasma albumin as standard. 
3. Results 
3 .I . Effects of mRNA synthesis inhibitors 
Fig.1 shows the effects of actinomycin D and cor- 
dycepin on the glutamine-modulated egradation of 
GS. ‘Induced’ cells containing high levels of glutamine 
synthetase were incubated, in the presence or absence 
of inhibitor, in medium without glutamine. Glutamine 
was added at various times after the addition of inhib- 
itor, and the incubation was continued. When gluta- 
mine was added at zero time with actinomycin D or 
cordycepin, GS activity decayed rapidly, at the same 
rate as in the control. After continued incubation with 
the inhibitors, the effect of glutamine on GS activity 
was progressively diminished and was completely 
abolished after 6 h. Essentially similar results were 
obtained with a-amanitin (not shown). 
3.2. Effect of enucleation 
Fig.2 shows that in cytoplasts, prepared by den- 
sity gradient centrifugation of HTC cells in the pres- 
ence of cytochalasin B, glutamine does not stimulate 
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Fig.2. Effect of enucleation on the glutaminedependent 
inactivation of GS. Induced HTC cells and cytoplasts prepared 
from these cells were incubated in ‘induction medium’. (0) 
Cells in absence of glutamine; (A) cytoplasts in absence of 
glutamine; (o) cells in the presence of 5 mM glutamine; (a) 
cytoplasts in the presence of 5 mM glutamine. At different 
times samples were taken for the estimation of the amount of 
protein and GS activity. 
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Table 1 
Effect of pretreatment with cytochalasin B on the glutamine- I 
SHORT LIVED PROTEINS 
dependent inactivation of GS (GS units/mg protein) 
20 
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cytochalasm B 
CYTOPLASTS 
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3 31 10 34 14 
Part of the cells were pre~cubated in the presence of 10 @g/ml 
cytochalasin B for 2 h. The cells were washed with ‘induction 
medium’, suspended in the same medium, and incubated for 
0,l and 3 h in the absence or presence of 5 mM glutamine. 
Control cells were treated the same way, omitting the prein- 
cubation with the inhibitor. Cells were harvested and GS 
activity and amount of protein were estimated as in section 2 
Lii 
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the decay of GS activity. Thus, enucleation, unlike 
the inhibition of mRNA synthesis, causes an immedi- 
ate abolition of the effect of glutamine. 
The possibility arose that the abolition of the glu- 
tamine effect was due to a toxic effect of cytochal- 
asin B, rather than to the enucleation itself. Table 1 
shows that the treatment of cells with cytochalasin B 
for 2 h, followed by its removal by washing the cells, 
had little or no effect on the glutamine-modulated 
decay of ~utam~e synthetase. Since the enucleation 
procedure involves exposure of the cells to cytochal- 
asin for only 1 h, a toxic effect of the cytochalasin B 
seems to be ruled out. 
Fig.3. Degradation of intracellular proteins in HTC cells and 
cytoplasts. Long- and short-lived proteins were labeled with 
[‘H]leucine as in section 2. The labeled cells (a) and the 
labeled cytoplasts (0) were suspended in ‘growth medium’. 
At different times samples were taken and the release of 
trichloroacetic acid-soluble radioactivity was determined. 
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Another possibility was that enucleation inhibits 
cellular protein degradation in general. Therefore the 
degradation of both ‘short-lived’ proteins and ‘long- 
lived’ proteins [4,8] was compared in cells and in 
cytoplasts. The turnover of both classes of proteins in 
cytoplasts was 60-70% of that found in the intact 
cells (fig.3). This rather small decrease in general pro- 
tein degradation is not likely to account for the com- 
plete and immediate effect of the enucleation on GS 
degradation. 
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According to this scheme, F is a labile polypeptide 
factor which, in the presence of glutamine, promotes 
GS modification and degradation. mRNA, is the spe- 
cific messenger RNA of the factor F. 
4. Discussion 
As the glutam~e~ependent degradation is rapidly 
inhibited by protein synthesis inhibitors, it was pro- 
posed that the factor F has a short half-life (-30 min) 
in the absence of glutamine [3]. Thus, the mainte- 
nance of a pool of F is dependent on its constant syn- 
thesis and, therefore, dependent on the m~ntenance 
of a pool of its messenger RNA (mRNAF). 
In [3] we suggested the following mechanism to The effects of the inhibitors of cytoplasmic mRNA 
explain the effects of protein synthesis inhibitors on synthesis (fig.1) could readily be explained in terms 
the glutamine-stimulated degradation of GS: of this model. The effect of glutamine is abolished 
February 1981 
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upon treatment for several hours with actinomycin D, 
cordycepin, and cY-amanitin. The fact that similar 
results were obtained with the 3 inhibitors, each of 
which is known to prevent the accumulation of cyto- 
plasmic mRNA by a different mechanism [9], suggests 
that the effects of the inhibitors on the degradation 
of GS is due to inhibition of the synthesis of a specific 
mRNA. If the life span of mRNA, were -6 h, then 
inhibition of its synthesis would result in a gradual 
decay and the eventual abolition of the glutamine 
effect. The data thus suggest hat the factor F involved 
in glutamine synthetase degradation is more labile 
than its mRNA. 
If the effect of enucleation were simply the removal 
of the source of cytoplasmic RNA, then the results of 
enucleation should be the same as those of inhibition 
of RNA synthesis. Since enucleation causes a complete 
and immediate cessation of the glutamine-stimulated 
degradation of GS,it seems that enucleation must have 
some effect additional to the depletion of mRNA,. 
Our experiments indicate that the loss of activity after 
enucleation is not due to non-specific toxicity of 
cytochalasin B or to a general inhibition of protein 
degradation. An alternative explanation is that enucle- 
ation removes or disrupts some unidentified cellular 
structure or function. Clearly, enucleation does more 
than simply stop the flow of RNA from the nucleus 
to the cytoplasm. Furthermore, the above results 
indicate that the degradation of GS involves enucle- 
ation-sensitive steps not shared with the degradative 
pathways of most other cellular proteins. 
As there is some disagreement in [ 10,l I] with 
respect to the effects of enucleation on protein turn- 
over, it is of interest that in our experiments the rate 
of general protein turnover was only slightly reduced 
in cytoplasts. In [lo] enucleation resulted in a com- 
plete inhibition of the degradation of the cellular pro- 
teins. In [l l] however, using two-dimensional elec- 
trophoresis, observed that enucleation does not affect 
the breakdown of many HTC cell proteins, although 
it does specifically inhibit the degradation of tyrosine 
aminotransferase and a few other specific proteins. 
Our results support the conclusions in [ 1 l] that enu- 
cleation does not strongly affect protein breakdown 
in general but may affect the degradation of individual 
proteins. 
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